Insulin degludec Subcutaneous and Tafenoquine (Malaria Prevention)
Determining the interaction of Insulin degludec Subcutaneous and Tafenoquine (Malaria Prevention) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Tafenoquine (Prevention of Malaria Relapse)
- Insulin degludec Subcutaneous-Tafenoquine Succinate (Arakoda)
- Insulin degludec Subcutaneous-Tafenoquine Succinate (Krintafel)
- Insulin degludec Subcutaneous-Tafinlar
- Insulin degludec Subcutaneous-Tafluprost
- Insulin degludec Subcutaneous-Tafluprost ophthalmic
- Tafenoquine (Malaria Prevention)-Insulin detemir
- Tafenoquine (Malaria Prevention)-Insulin Detemir (Cartridges and Prefilled Syringes)
- Tafenoquine (Malaria Prevention)-Insulin Detemir (Vials)
- Tafenoquine (Malaria Prevention)-Insulin detemir Subcutaneous
- Tafenoquine (Malaria Prevention)-Insulin glargine
- Tafenoquine (Malaria Prevention)-Insulin Glargine (U-100) Cartridge Systems and Pens